Belpointe Asset Management LLC Edwards Lifesciences Corp Transaction History

Belpointe Asset Management LLC

$1.24 Billion
Q1 2024

A detailed history of Belpointe Asset Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Belpointe Asset Management LLC holds 2,181 shares of EW stock, worth $201,349. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,181

Holding current value

$201,349

% of portfolio

0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$72.54 - $95.56 $158,209 - $208,416	2,181 New	2,181 $208,000
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $23,614 - $26,874	318 Added 15.74%	2,338 $193,000
Q4 2022 Feb 08, 2023	SELL	$68.3 - $87.44 $341 - $437	-5 Reduced 0.25%	2,020 $150,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $37,972 - $49,460	461 Added 29.48%	2,025 $167,000
Q2 2022 Aug 02, 2022	SELL	$86.5 - $128.27 $605 - $897	-7 Reduced 0.45%	1,564 $148,000

Q1 2022 Apr 28, 2022	SELL	$101.96 - $128.34 $29,466 - $37,090	-289 Reduced 15.54%	1,571 $185,000
Q4 2021 Feb 15, 2022	SELL	$106.37 - $130.68 $30,528 - $37,505	-287 Reduced 13.37%	1,860 $240,000
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $61,848 - $73,772	601 Added 38.87%	2,147 $243,000
Q2 2021 Aug 09, 2021	BUY	$83.84 - $104.76 $129,616 - $161,958	1,546 New	1,546 $160,000
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $99,294 - $114,425	-1,262 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $1,935 - $2,463	-27 Reduced 2.09%	1,262 $115,000
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $34,737 - $45,206	517 Added 66.97%	1,289 $103,000
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $123,360 - $160,539	-1,836 Reduced 70.4%	772 $146,000
Q2 2020 Jul 20, 2020	BUY	$57.54 - $76.95 $105,643 - $141,280	1,836 Added 237.82%	2,608 $180,000
Q1 2020 Jul 20, 2020	SELL	$52.41 - $81.0 $113,572 - $175,527	-2,167 Reduced 73.73%	772 $146,000
Q4 2019 Feb 18, 2020	BUY	$71.7 - $82.09 $128,414 - $147,023	1,791 Added 156.01%	2,939 $686,000
Q3 2019 Jan 16, 2020	SELL	$61.55 - $75.43 $11,879 - $14,557	-193 Reduced 14.39%	1,148 $252,000
Q2 2019 Nov 22, 2019	BUY	$55.74 - $64.41 $19,620 - $22,672	352 Added 35.59%	1,341 $0
Q1 2019 Jun 11, 2019	BUY	$47.89 - $64.05 $9,386 - $12,553	196 Added 24.72%	989 $189,000
Q4 2018 Mar 06, 2019	SELL	$46.41 - $56.94 $139,230 - $170,820	-3,000 Reduced 79.09%	793 $121,000
Q3 2018 Nov 23, 2018	BUY	$45.7 - $58.03 $30,390 - $38,589	665 Added 21.26%	3,793 $660,000
Q2 2018 Aug 06, 2018	BUY	$42.45 - $51.3 $5,560 - $6,720	131 Added 4.37%	3,128 $455,000
Q1 2018 Aug 06, 2018	SELL	$37.19 - $47.45 $17,814 - $22,728	-479 Reduced 13.78%	2,997 $418,000
Q4 2017 Feb 15, 2018	BUY	$33.79 - $39.39 $7,873 - $9,177	233 Added 7.18%	3,476 $392,000
Q3 2017 Nov 16, 2017	BUY	$36.29 - $38.83 $117,688 - $125,925	3,243	3,243 $354,000

Others Institutions Holding EW

# of Institutions

1,378

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Account

Belpointe Asset Management LLC Edwards Lifesciences Corp Transaction History